ADHD & Perimenopause: Brain Fog, Focus, Sleep & Mood

Perimenopause and ADHD can produce overlapping complaints

Many women reach midlife and notice changes in concentration, memory, sleep, mood, energy, or organization. For someone who already has ADHD—or who is wondering whether lifelong attention difficulties may represent ADHD—this can be confusing.

Perimenopause and ADHD are different clinical issues, but some symptoms can overlap. The important question is not whether every midlife attention problem is “hormonal” or “ADHD.” The goal is to understand what changed, what was present earlier in life, and which factors are contributing now.

What happens during perimenopause?

Perimenopause is the transition leading up to menopause. The American College of Obstetricians and Gynecologists (ACOG) explains that ovarian estrogen production fluctuates during this period.

Common symptoms can include:

• changes in menstrual cycles
• hot flashes and night sweats
• sleep disruption
• vaginal and urinary symptoms
• changes in well-being that may affect daily functioning

Night sweats and insomnia can also leave a person tired or less mentally sharp during the day.

ADHD should have a lifelong pattern

Adult ADHD is not simply new difficulty concentrating in the 40s or 50s.

ADHD is a neurodevelopmental disorder. For an adult diagnosis, clinicians look for a persistent pattern of symptoms and evidence that symptoms were present earlier in life, including before age 12, even if they were not formally diagnosed at that time.

That distinction matters because new concentration problems in midlife can also be associated with sleep disruption, depression, anxiety, medication effects, thyroid disease, anemia, substance use, menopause-related symptoms, and other medical conditions.

What does research say about hormones and ADHD?

Research in this area is growing, but important gaps remain.

A 2025 systematic review of ADHD and sex hormones in females found suggestive evidence that hormonal changes may be associated with changes in ADHD symptoms, particularly across puberty and the menstrual cycle. However, the review emphasized that the evidence base was small and heterogeneous.

Importantly, that review found that empirical research specifically examining ADHD during menopause was lacking.

So it is reasonable for clinicians to ask whether symptoms vary with hormonal life stages, but it would be too strong to say that menopause has been proven to worsen ADHD in every woman.

Sleep may be an important bridge between symptoms

Perimenopause commonly disrupts sleep. Hot flashes may wake someone repeatedly, while insomnia can make it difficult to fall asleep or stay asleep.

Poor sleep itself can impair attention, memory, reaction time, emotional regulation, and decision-making. This means a woman with ADHD may feel less able to compensate for longstanding executive-function challenges when sleep deteriorates.

Sleep apnea also becomes an important consideration in midlife, especially when symptoms include snoring, daytime sleepiness, morning headaches, or unrefreshing sleep.

Mood symptoms can also affect concentration

Anxiety and depression can both cause or worsen difficulty concentrating. They can also coexist with ADHD.

A careful assessment may therefore explore:

• whether attention problems were present in childhood or young adulthood
• whether symptoms changed with perimenopause
• sleep quality and night sweats
• anxiety, depression, irritability, or emotional changes
• current ADHD medication response
• other medications or substances
• menstrual history and menopausal symptoms
• relevant medical contributors

Does hormone therapy treat ADHD?

Menopausal hormone therapy is used to treat appropriate menopausal symptoms in selected patients after individualized risk-benefit discussion.

It should not currently be presented as an established treatment for ADHD itself.

Research has not established that menopausal hormone therapy reliably treats ADHD symptoms or replaces standard ADHD evaluation and treatment. A patient may appropriately receive treatment for both ADHD and menopausal symptoms, but each decision should have its own clinical indication.

What if ADHD medication seems less effective?

A perceived change in medication effect deserves reassessment rather than an automatic dose increase.

Clinicians may consider:

• sleep deterioration
• inconsistent medication use
• new medications or supplements
• anxiety or depression
• changing daily demands
• substance use
• cardiovascular or other medical changes
• menopausal symptoms
• whether the original ADHD treatment plan still fits

Medication changes should be individualized and supervised by the treating clinician.

When to seek evaluation

Consider evaluation when:

• attention or executive-function symptoms are interfering with work or home life
• symptoms have changed substantially during midlife
• sleep has become persistently poor
• hot flashes or night sweats are disrupting daily function
• mood or anxiety symptoms are increasing
• you are unsure whether symptoms represent ADHD, menopause, another medical condition, or several factors together

Bottom line

Perimenopause can affect sleep and well-being, and those changes can resemble or amplify problems with attention and executive function.

There is growing interest in the relationship between sex hormones and ADHD symptoms, but research specific to menopause remains limited. Good care avoids assuming that every cognitive symptom is caused by hormones—or that every attention complaint is ADHD.